申请人:Wyeth
公开号:US06706757B2
公开(公告)日:2004-03-16
The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor.
本发明提供了一种式I的化合物以及其在治疗与或受5-HT6受体影响的疾病方面的应用。